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\s=b\Estimates of the prevalence of depression in idiopathic
Parkinson's disease vary, but have been greater than in most
comparison groups. In a survey of patients with Parkinson's
disease (N = 339), the prevalence of depression was 47%. A
total of 326 cases were reviewed to estimate the incidence
of depression from September 30, 1984, to July 31,1989. As-
sessments of depression during both the prevalent and the in-
cident periods were noted in 258 cases. There was no history
of depression in 129 cases, and nine new cases occurred. The
incidence rate was 1.86% per year and the cumulative risk was
8.6%. Published estimates of the incidence of depression in the
general population are few. In one study, the annual incidence
of depression in individuals older than 40 years was 0.17%. In
another, the incidence of depression in individuals older than
50 years was 0.14% for men and 0.29% for women. Although
our retrospective study probably underdiagnoses depression,
the incidence of depression is increased in Parkinson's disease.(Arch Neurol. 1992;49:305-307)
Estimates of the prevalence ofdepression in idiopathic Par¬kinson's disease (PD) vary, but have been greater than
in most comparison groups.1 The prevalence of depression
is a function of the incidence of the new onset, duration, and
recurrence rate of depressive episodes. We theorized that an
estimate of the incidence, rather than the prevalence, would
provide a better measure of the risk of depression in PD. In
a survey of patients with PD that was completed on Septem¬
ber 30, 1984, we noted the prevalence of depression to be
47% .2 The current study estimates the incidence and the cu¬
mulative risk of depression in the same cohort of patients
with PD based on a second review of the medical records 4
years and 10 months later.
SUBJECTS AND METHODS
Subjects
All patient-records were obtained from the Columbia-
Presbyterian Medical Center (CPMC), New York, NY. The medical
center functions as both a tertiary referral center and a community
hospital for northern Manhattan. The records of all patients with
parkinsonism seen at CPMC between March 1, 1983, and Septem¬
ber 30,1984 (N = 442), were reviewed. Three hundred thirty-nine of
the patients were judged to have idiopathic PD with onset at the age
of 40 years or older and were included in a prior study.2 No new
patients were entered into the cohort.
Data Extraction
All records were reviewed to determine the presence or
absence of depression from September 30, 1984, to luly 31, 1989,
a period of 4 years and 10 months. A data extraction form was
developed for the process of record review. The date when de¬
pression was first diagnosed and the date of the last chart entry
were recorded. When the date of the onset of depression was
unclear, we used the midpoint between September 30,1984, and
the date of the last chart entry as the estimated date of onset.
Subjects not examined at the medical center after September 30,
1984, were tracked and telephoned. These subjects, or their respon¬
sible family member, were questioned using a structured interview
to obtain information identical to that on the data extraction form.
For these cases, the date of last entry was luly 31, 1989.
Diagnostic Criteria
We used criteria for depression modified from the Diagnostic
and Statistical Manual of Mental Disorders, Revised Third Edition.3 A
unified Parkinson's disease rating scale4 score of 3 or more on the
depression item was accepted as diagnostic. According to this
scale, 0 indicates no depression; 1, periods of sadness or guilt,
never sustained for days or weeks; 2, sustained depression (1
week or longer); 3, sustained depression with vegetative symp¬
toms (insomnia, anorexia, weight loss, loss of interest); and 4,
sustained depression with vegetative symptoms and suicidal
thoughts or intent. Otherwise, depression was defined as a per¬
sistently depressed mood (not a grief reaction, eg, following the
death of a spouse) or a feeling of sadness or being "down-in-
the-dumps" associated with a loss of interest in usual activities
and with vegetative signs and symptoms.
For the diagnosis of depression, the following guide was used
to assess the quality of diagnostic assurance:
1. Definite. A neurologist or psychiatrist made the diagnosis
and recorded the information in the chart.
2. Probable. All of the signs and symptoms were present, but a
"qualified" examiner had not written the diagnosis in the record.
3. Possible. Symptoms and signs were mentioned by nurses,
social workers, or other health professionals, but no diagnosis
had been made. For telephone interviews, the diagnosis of de¬
pression was always considered "possible" unless we spoke to
the patient's physician.
Only first episodes of depression were considered.
Data Analysis
Incidence rates, cumulative risk, and standardized morbidity
ratios (SMRs) were calculated as described by Rothman.5 The
SMRs were computed in comparison with age- and sex-specific
rates from the studies by Essen-Moller and Hagnell,6 Hagneil et
al,7 and Murphy et al.8
RESULTS
The Figure outlines the flow of the original cohort; 339 pa¬
tients with PD were considered eligible for this review. No
records were available for 13. Two had not been rated on the
depression item, and 14 were rated "don't know" during the
initial survey. Of the remaining 310, 41 had no rating of de¬
pression during the incident period, as there was no new in¬formation in the medical records and we were unable to lo¬
cate the patient or family. An additional 11 were rated "don't
know" during the incident period. This left 258 records for
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review; 129 of these patients had been considered depressed
in the previous study. Therefore, we began our review with
the records of 129 patients who had not previously been de¬
pressed . There were 39 (30% ) women and 90 (70% ) men (pro¬
portions similar to those in the original cohort [127 women
and 199 men]). The mean age of this group at last chart entry
was 71.5±9.3 years.
After review of the 129 patient-records, 120 of the patients
still did not demonstrate evidence of depression. First onset
of depression was noted in nine patients. In seven cases, de¬
pression was clearly defined and the approximate date of on¬
set was noted in the record. In two patients, the onset of de¬
pression clearly occurred after September 30, 1984, but thedate of onset could not be established. The diagnostic cer¬
tainty was definite in seven cases, probable in one case, and
possible in one. The aggregate follow-up for the 129 patientsfrom the end of the prevalent period until either the last chart
entry or the date of onset of depression was 483 person-
years. The incidence rate of depression in this cohort was
therefore 1.86% per year, with 95% confidence interval from
1.16% to 2.56% (Table 1). The cumulative risk for depression
was 8.6% during this period.
Table 2.—Comparison of Nondepressed andDepressed Patients*
Nondepressed Depressed
No. 120 9
Male:female (ratio) 83:37 (2.2) 7:2 (3.5)
In-patient 12 (10%) 1 (11%)
Age, y 71.6±9.4 70.0±6.1
Age at onset of PD, y 58.8±11.0 58.7±9.7
Duration of disease, y 8.1 ±6.6 6.8±4.2
Duration of levodopa
therapy, y 5.8±4.6 5.4±4.7
Family history of PD 20 (16%) 1 (11%)
Responders to levodopa 90 (87%) 6 (86%)t
Used dopa agonists 21 (18%) 2 (22%)
Tremulous 79 (66%) 6 (67%)
ADL (on), % 67.6±33.9 71.1±27.5
ADL (off), % 38.8±40.1 33.3±35.1
Benign course 12 (11%) 2 (22%)
Average course 101 (89%) 6 (67%)
Rapid course 0 1 (11%)
PD indicates Parkinson's disease; ADL, activities of daily living
rating.
tData missing for two patients.
As shown in Table 2, the grotip that became depressed
and the group that remained nondepressed did not differ
significantly with respect to age, sex, age at onset of PD,
duration of levodopa therapy, response to levodopa
therapy, use of dopa agonists, family history of PD, pres¬
ence of tremor, or impairment of activities of daily living
rating (on the Schwab and England9 activities of daily liv¬
ing scale). The course of illness (rapid, average, or benign)did not predict depression. The average duration of PD
was shorter in the depressed group, but this difference
did not reach statistical significance.
Age- and sex-specific SMRs for depression incidence
rates revealed an overall SMR of 41.5; ie, depression was
found 41.5 times more frequently in the patients with PD
than would be expected in a general population, using the
population study of Essen-Moller and Hagnell6 to gener¬
ate expected rates of depression. When data from the ex¬
tension of this study were used,7 the overall SMR fell to
10.3. Finally, the use of the sex-specific rates from the
study by Murphy et al8 revealed an SMR for depression
incidence of 3.8 in women older than 50 years and an SMR
of 148.9 for men older than 50 years.
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COMMENT
Depression is probably the most common mental distur¬bance in PD.1 Forty-seven percent of the patients with PD
who we reviewed were depressed during the initial survey.2
In a review of 14 studies that included more than 1500 pa¬
tients, Gotham et al10 estimated the mean prevalence of de¬
pression in PD to be 46%, although prevalence ranged from
20% to as high as 90% in these studies. Different sampling
and assessment techniques may have accounted for much of
the variation. In the healthy elderly population, Boyd and
Weissman, " in their review, noted that the point prevalence
of depression was 3% for men and 4% for women. This cer¬
tainly suggests that depression is more prevalent in individ¬
uals with PD than in the healthy elderly.
While the prevalence of depression has been described,
and is higher in patients with PD than in age-matched con¬
trols, the incidence of depression in PD is unknown. In fact,
the incidence of nonbipolar depression has rarely been re¬
ported. Boyd and Weissman11 concluded that the lifetime
risk for depression was 8% to 12% for men and 20% to 26%
for women, but they felt that they could not confidently es¬
timate the incidence of depression from 12 studies reporting
this statistic. Nine were case-registry studies, and the three
longitudinal studies used varying diagnostic methods. The
incidence rates ranged from 0.13% peryearto7.8% peryear.Our figure of 1.86% per year fell within this broad range.
In a study that employed an analysis of data from
interviews with probands and their relatives and hospital
records in a small rural district of Scania (the Lundby
study),6 the prevalence of depression in the adult popu¬
lation was 3.7% for women and 2.1% for men in 1947. A
rereview of nearly 99% of the original cohort in 1957
yielded 15 new cases of depression among those who
were older than 40 years in 1947 during an aggregate
follow-up of 8931 person-years —equivalent to an inci¬
dence rate of 0.17% per year. An additional review of this
cohort, conducted in a similar fashion, revealed 104 new
cases in the period from 1957 to 1972 (with an aggregate
follow-up of 15404.4 person-years) among those older
than 40 years in 1957, yielding an incidence rate of 0.68%
per year.7 Murphy et al8 reported an incidence of depres¬
sion of 0.14% per year for men older than 50 and an in¬
cidence of 0.29% per year for women older than 50 in a
follow-up of a cohort of previously nondepressed subjects
first interviewed in 1952 in the Stirling county study.8
Both the Lundby and the Stirling county studies were
based primarily on interviews and were performed pro¬
spectively. Our study was a retrospective chart review.
Cases might have been missed in our study, since the ap¬
propriate information might not have been sought or
systematically recorded at the time of the examinations.As a result, our figures probably underestimate the inci¬
dence of depression in this cohort of patients with PD.
Even so, the SMRs calculated with respect to the Lundby
and Stirling county studies suggest that the incidence of
depression is considerably higher in individuals with PD
than in general populations of similar ages.
While there are no other studies reporting the incidence
of depression in PD, Brown et al,12 in their follow-up of
132 patients with PD noted that 15 of 96 previously non-
depressed patients became depressed (on the basis of
self-rating on the Beck Depression Inventory13) during a
follow-up period with a median of 14 months. While they
did not report an incidence rate, assuming a mean (rather
than median) follow-up of 14 months among the 81 non-
depressed patients, and that the 15 newly depressed pa¬
tients had an onset of depression at an average of half the
median follow-up period (7 months), then the aggregate
follow-up for this cohort would be 103.5 person-years and
an estimated incidence of depression would be 14.5% per
year. This figure, however, must be regarded as a very
rough approximation, given the nature of the method
used to calculate it. Comparability with our data suffers
from the differing criteria used (the Beck Depression In¬
ventory vs the Diagnostic and Statistical Manual of Mental
Disorders-Revised Third Edition), as well as from differences
in the method of data collection (self-report vs chart
review). However, Brown and colleagues' data also sug¬
gest a high incidence of depression in PD.Our study is limited in many respects. Review of
records may be insufficient to reliably assess the presence
of depression, since the data are not always specifically
asked for in routine visits. Psychiatric interviews were not
performed nor were any depression measures adminis¬
tered systematically to this cohort. There was no "inter¬
nal" comparison group reviewed in a similar fashion that
could be used as controls. However, we believe that these
factors would tend to produce an underestimate of the
incidence of depression in PD and that our figures are
therefore probably conservative estimates. The utility of
these data is that they allow the clinician to predict about
an 8% to 9% chance of patients with PD developing de¬
pression over a 5-year period. A better estimate of the
morbidity due to depression in PD awaits the completion
of a prospective longitudinal follow-up (including psy¬
chiatric assessment) of a large cohort of patients with PD.
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